EMA-EORTC workshop underscores critical role of patient-reported outcomes and quality of life data in regulatory decision-making
Highlights from a joint European Medicine Agency (EMA) and European [...]
New study confirms link between cancer patients’ quality of life and survival GalleryNew study confirms link between cancer patients’ quality of life and survival
News, Brain Tumour Group, Breast Cancer Group, Cutaneous Lymphoma Tumours Group, Diagnostic and Therapeutic Imaging, Endocrine Tumours Group, Gastrointestinal Tract Cancer Group, Genito-Urinary Cancers Group, Gynecological Cancer Group, Head and Neck Cancer Group, Leukemia Group, Lung Cancer Group, Lymphoma Group, Melanoma Group, Older Adults Council, Pathobiology Group, Pharmacology & Molecular Mechanisms Group, Quality of Life Group
New study confirms link between cancer patients’ quality of life and survival
A major new study by Lim et al.1, published at [...]
SISAQOL-IMI consortium launches final recommendations
The European Organisation for Research and Treatment of Cancer (EORTC) [...]
EORTC Quality of Life Group’s participation to ISOQOL 2024
We are delighted to announce the participation of the EORTC [...]
EORTC Quality of Life measures integrated in CDISC
The European Organisation for Research and Treatment of Cancer (EORTC) [...]
EORTC Quality of Life Group projects to be presented at ISOQOL 2023
In October, a number of the EORTC Quality of [...]
Full validation of the EORTC CAT Core
Brussels, 6 June 2023 – Following almost 20 years [...]
SISAQOL-IMI: Setting standards for the use of patient-reported outcome data in cancer trials
Brussels, 1 June 2023 – Today , the European [...]
Synthesis of minimally important differences for interpreting EORTC QLQ-C30 change scores across nine cancer types
Brussels, 30 May 2023 - The European Organisation for [...]
EORTC QLG proudly collaborates on the EUonQoL project
Brussels, 21 March 2023 - The European Organisation for [...]
